Neurones S.A. (LON:0GX2)

Neurones Statistics

Total Valuation

Neurones has a market cap or net worth of GBP 807.52 million. The enterprise value is 645.21 million.

Market Cap	807.52M
Enterprise Value	645.21M

Important Dates

The next estimated earnings date is Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	Jun 11, 2025

Share Statistics

Current Share Class	24.32M
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	4.41%
Owned by Institutions (%)	10.38%
Float	12.08M

Valuation Ratios

The trailing PE ratio is 18.57.

PE Ratio	18.57
Forward PE	n/a
PS Ratio	1.13
PB Ratio	2.18
P/TBV Ratio	3.05
P/FCF Ratio	14.20
P/OCF Ratio	12.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.06, with an EV/FCF ratio of 11.34.

EV / Earnings	14.83
EV / Sales	0.89
EV / EBITDA	8.06
EV / EBIT	10.05
EV / FCF	11.34

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.10.

Current Ratio	2.31
Quick Ratio	2.24
Debt / Equity	0.10
Debt / EBITDA	0.45
Debt / FCF	0.62
Interest Coverage	32.86

Financial Efficiency

Return on equity (ROE) is 14.64% and return on invested capital (ROIC) is 10.05%.

Return on Equity (ROE)	14.64%
Return on Assets (ROA)	6.61%
Return on Invested Capital (ROIC)	10.05%
Return on Capital Employed (ROCE)	15.75%
Revenue Per Employee	99,241
Profits Per Employee	6,051
Employee Count	7,087
Asset Turnover	1.19
Inventory Turnover	415.97

Taxes

In the past 12 months, Neurones has paid 20.07 million in taxes.

Income Tax	20.07M
Effective Tax Rate	27.80%

Stock Price Statistics

The stock price has decreased by -13.24% in the last 52 weeks. The beta is 0.52, so Neurones's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-13.24%
50-Day Moving Average	40.99
200-Day Moving Average	44.89
Relative Strength Index (RSI)	34.74
Average Volume (20 Days)	31

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neurones had revenue of GBP 713.34 million and earned 43.49 million in profits. Earnings per share was 1.78.

Revenue	713.34M
Gross Profit	343.93M
Operating Income	63.34M
Pretax Income	72.19M
Net Income	43.49M
EBITDA	71.52M
EBIT	63.34M
Earnings Per Share (EPS)	1.78

Balance Sheet

The company has 247.47 million in cash and 35.55 million in debt, giving a net cash position of 211.92 million.

Cash & Cash Equivalents	247.47M
Total Debt	35.55M
Net Cash	211.92M
Net Cash Per Share	n/a
Equity (Book Value)	370.02M
Book Value Per Share	13.10
Working Capital	279.60M

Cash Flow

In the last 12 months, operating cash flow was 66.82 million and capital expenditures -9.93 million, giving a free cash flow of 56.89 million.

Operating Cash Flow	66.82M
Capital Expenditures	-9.93M
Free Cash Flow	56.89M
FCF Per Share	n/a

Margins

Gross margin is 48.21%, with operating and profit margins of 8.88% and 6.10%.

Gross Margin	48.21%
Operating Margin	8.88%
Pretax Margin	10.12%
Profit Margin	6.10%
EBITDA Margin	10.03%
EBIT Margin	8.88%
FCF Margin	7.97%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 2.84%.

Dividend Per Share	1.10
Dividend Yield	2.84%
Dividend Growth (YoY)	8.72%
Years of Dividend Growth	2
Payout Ratio	62.33%
Buyback Yield	-0.08%
Shareholder Yield	2.76%
Earnings Yield	5.39%
FCF Yield	7.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neurones has an Altman Z-Score of 4.39 and a Piotroski F-Score of 6.

Altman Z-Score	4.39
Piotroski F-Score	6